Document is current
Any future updates will be listed below
-
Authors
Mori, Yuriko
Novruzov, Emil
Schmitt, Dominik
Cardinale, Jens
Watabe, Tadashi
Choyke, Peter L.
Alavi, Abass
Haberkorn, Uwe
Giesel, Frederik L.
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 21 October 2024
First Online: 13 November 2024
Competing interests
: F.L.G. has a patent application for quinolone-based FAP-targeting agents for imaging and therapy in nuclear medicine and is a shareholder of a consultancy group for iTheranostics. F.L.G. is also an advisor at ABX, Telix, Alpha Fusion, and SOFIE Biosciences. U.H. receives royalties from iTheranostics and SOFIE Biosciences and possesses a patent for FAPI tracers licensed to SOFIE Biosciences. The other authors declare no conflict of interest regarding this manuscript.
